13855-90-8

Basic information

• Product Name: 2,2,5,5-tetramethylcyclohex-3-en-1-one
• Synonyms: 2,2,5,5-tetramethylcyclohex-3-en-1-one
• CAS NO: 13855-90-8
• Molecular Weight: 152.236
• Mol File: 13855-90-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2,2,5,5-tetramethylcyclohex-3-en-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2,5,5-tetramethylcyclohex-3-en-1-one(13855-90-8)
• EPA Substance Registry System: 2,2,5,5-tetramethylcyclohex-3-en-1-one(13855-90-8)

Safety Data

• Hazardous Substances Data: 13855-90-8(Hazardous Substances Data)

Upstream product

• 1703-82-8 3-hydroxy-2,2,5,5-tetramethylcyclohexanone 
• 702-50-1 2,2,5,5-tetramethylcyclohexa-1,3-dione 
• 15500-76-2 Dimethyl-dimedon-mono-(toluol-4-sulfonyl-hydrazon) 

Downstream Products

• 1083308-96-6 (1S)-2,2,5,5-tetramethylcyclohex-3-en-1-ol 
• 1104383-71-2 (3R,4R)-3-bromo-4-hydroxy-2,2,5,5-tetramethylcyclohexanone 
• 1083308-99-9 (3S,4S)-4-bromo-3-hydroxy-2,2,5,5-tetramethylcyclohexanone 
• 26771-06-2 (-)-cis-chrysanthemic acid 
• 26771-11-9 (1R)-cis-chrysanthemic acid 
• 1104383-73-4 (1R,6R)-6-bromo-2,2,5,5-tetramethyl-4-oxocyclohexyl methanesulfonate 
• 1104383-72-3 (1S,6S)-6-bromo-2,2,5,5-tetramethyl-3-oxocyclohexyl methanesulfonate 
• 1432439-20-7 (1R,6R)-6-bromo-2,2,5,5-tetramethyl-3-oxocyclohexyl methanesulfonate 
• 1432439-18-3 (1S,3R,4R)-1-acetoxy-4-bromo-3-(mesyloxy)-2,2,5,5-tetramethylcyclohexane 
• 1442007-65-9 C₁₃H₂₃BrO₅S 
• 1442008-51-6 C₁₃H₂₃BrO₅S 
• 1432439-13-8 (1S)-1-acetoxy-4-bromo-3-hydroxy-2,2,5,5-tetramethylcyclohexane 
• 1432439-15-0 (1S)-1-acetoxy-3-bromo-4-hydroxy-2,2,5,5-tetramethylcyclohexane 
• 1432439-16-1 (1S)-1-acetoxy-3-bromo-4-hydroxy-2,2,5,5-tetramethylcyclohexane 

Relevant articles and documents

SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS RXR AGONISTS

The present invention relates to certain substituted bicyclic compounds that are agonists of RXR and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders.

Isomerisation of 2,2-dimethyl dimedone to (D,L) cis-chrysanthemic acid

(D,L) cis-Chrysanthemic acid has been obtained in four steps from 2,2- dimethyl dimedone which involves Bamford-Stevens olefination and tandem cyclization-Grob fragmentation reactions. (C) 2000 Published by Elsevier Science Ltd.